Advances in Diabetes Treatment 2005 - Second Annual Conference.
Harwood
H James
HJ
Pfizer Global Research and Development, Department of Cardiovascular and Metabolic Diseases, Groton Laboratories, CT 06340, USA. h.james.harwood@pfizer.com
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000818:Animals; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D004353:Drug Evaluation, Preclinical; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation; D051381:Rats; D011924:Rats, Zucker; D033581:Stem Cell Transplantation
D007328:Insulin; D038362:Glycogen Synthase Kinase 3